Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
Meylan
Pascal R-A
PR
Pascual
Manuel
M
D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D009894:Opportunistic Infections / Q000517:prevention & control; D016377:Organ Transplantation / Q000009:adverse effects*; D011315:Preventive Medicine; D014180:Transplantation
D000998:Antiviral Agents; D015774:Ganciclovir